ME AWARENESS 2026
Campaigning
M.E awareness for 2026
Awareness helps in several ways: it educates the public and healthcare providers, reducing stigma and promoting early diagnosis; it drives funding for research into causes and treatments, as there’s currently no cure; and it fosters empathy and support for those living with ME, who often feel isolated due to the condition’s impact on their daily lives. By shining a light on ME, we can improve quality of life for millions and push for better medical and social resources.
raising awareness for 2026
Raising awareness for Myalgic Encephalomyelitis (ME), also called Chronic Fatigue Syndrome (CFS), is vital because it’s a misunderstood and often invisible illness. ME is a severe, chronic condition that impacts multiple body systems, leading to extreme fatigue, pain, brain fog, and post-exertional malaise—where even small activities worsen symptoms.
This Years Focus
May ME Awareness Month
As part of M.E. Awareness Month this May, we’re pleased to share a new resource created especially for people living with severe and very severe ME, as well as those who support and care for them. This short document explains, in clear everyday language, what severe ME really is, why it requires such careful handling, and how the right approaches can dramatically reduce harm and distress. Many people with severe or very severe ME are unable to speak for themselves, advocate for their needs, or correct the misunderstandings that too often surround this illness — which is why this resource is designed to do that work on their behalf.
The guidance sets out practical, straightforward ways that carers, family members, friends, visiting professionals, home‑care staff and medical teams can support someone safely. It covers the essential principles of reducing sensory input, avoiding over‑exertion, recognising post‑exertional malaise, removing unnecessary demands, and prioritising calm, quiet, low‑stimulus environments. It also includes clear reminders of what not to do — such as encouraging exercise, suggesting therapy as a cure, or assuming the illness is psychological. These points are especially important for those who are new to ME or who may only have seen outdated or inaccurate information.
We encourage our members to share this document with anyone involved in their care or daily life — whether that’s a GP, consultant, community nurse, home‑care provider, social worker, family members, friends, neighbours, or support staff. You may also wish to send it to schools or colleges where appropriate, or anyone else who needs to understand the realities of severe ME and the absolute importance of minimising harm. Sometimes a single clear explanation can transform how someone interacts with a person living with this condition.
This resource is designed to act as a shield as much as a guide — helping reduce misunderstanding, preventing unintentional harm, and giving your wider circle the confidence to support you safely. It’s a simple tool with a big purpose: protecting energy, reducing pressure, and making day‑to‑day life a little easier for those who live with the most severe forms of ME.
You’ll find the full document enclosed. Please feel free to pass it on to anyone who may benefit from reading it.
GAME ME-ICC
A very important observation in ME (Myalgic Encephalomyelitis, especially ME-ICC). There’s growing evidence that post-exertional changes in ME patients are highly individualized at the molecular level, even if the clinical outcome like fatigue or post-exertional malaise is similar.
Exercise as a Molecular Stress Test
* In research, exercise (often a cardiopulmonary exercise test or CPET) is used as a stress challenge to reveal hidden dysfunctions.
* For ME patients, this isn’t just physical fatigue. It triggers neuroimmune, metabolic, and transcriptional changes.
* Studies show that the same exercise can provoke very different molecular responses in different patients, even if their symptoms look similar.
Implications
* Heterogeneity explains why a one-size-fits-all treatment fails. Molecular data show ME is not a single disease mechanism but a spectrum of dysregulations.
* Potential for molecular subtyping: Patients could be grouped by their molecular response profile, e.g., immune-dominant vs. metabolism-dominant post-exertional changes.
* Relevance to post-exertional Neuroimmune exhaustion (PENE). The individualized molecular changes correlate with severity and type of PENE , explaining why two patients can do the same exercise but have very different symptom profiles afterwards.
4. Supporting Studies
*Light et al., 2012 – Gene expression in immune cells shows distinct post-exercise transcriptional changes in ME patients versus controls. Some patients had dramatic upregulation of stress and inflammation genes, others had muted responses. https://pmc.ncbi.nlm.nih.gov/articles/PMC3175315/
*Armstrong et al., 2015 – Metabolomic profiling found heterogeneous post-exercise changes in energy metabolites. https://findanexpert.unimelb.edu.au/…/981475-metabolic…
*/Naviaux et al., 2016 (metabolic network analysis) – Suggests ME patients’ metabolic responses to stress are individualized “cell danger response” profiles. https://pubmed.ncbi.nlm.nih.gov/27573827/
Bottom line: ME patients respond differently at a molecular level to exercise due to heterogeneity in immune, metabolic, and mitochondrial pathways. This heterogeneity is why exercise testing can uncover disease mechanisms but also why patients’ post-exertional experiences are so variable.
#GAME
#NightingaleContinuum
Thanks to Wendy Boutilier
“This is not a psychological disease”
Thanks to Broken Battery …
Professor Chris Ponting on the 116 blood molecule differences his team found in people with #MECFS
“This is not a psychological disease” people did not alter their blood molecules just to “spook the psychiatrists”.
Clip from Hope 4 ME & Fibro NI 2026
NEW RESOURCE FOR PATIENTS – M.E. Clinical Update Cards
These business cards have been designed for people living with M.E. to hand directly to their GP, hospital doctor, nurse or other healthcare professional.
This idea came from one of our severe M.E. members, Neil McCalmont, following several recent hospital admissions where a lack of knowledge about M.E. became very clear.
The cards direct healthcare professionals to a free, evidence-based 1-hour M.E. Clinical Update webinar, Hope 4 ME & Fibro N.I. developed in partnership with General Practice Northern Ireland (GPNI)
The QR code on the front takes GPNI members directly to the clinical update. Non-GPNI members — any healthcare professional — can use the QR code on the back to request the webinar access code.
The card also highlights the importance of:
• Recognising post-exertional malaise (PEM)
• Avoiding harm
• Ensuring safe, appropriate management
Sometimes advocacy looks like a protest.
Sometimes it looks like quietly placing a card on a desk and saying, “Please take a look at this.”
A massive thank you to our member Neil 
Details to follow on how these cards can be ordered to keep handy in your purse or wallet.
Full details and credits on the GPNI Clinical Update here – https://www.hope4mefibro.org/gpni-me-webinar
Design by colincranney.com
#myalgicEncephalomyelitis #MECFS #PatientSafety #EducationMatters #Hope4ME #volunteers #PatientsHelpingPatients
The Nightingale Continuum
People with ME/ICC often describe a progressive loss of functional capacity that can feel like “fading away,” as the illness steadily reduces energy availability, cognitive endurance, and physical tolerance. This is not simple fatigue, but a systemic impairment of energy production and recovery, where even minimal exertion can lead to disproportionate and prolonged deterioration rather than normal recovery. Over time, patients may be forced into an ever-narrowing envelope of tolerable activity, with a marked reduction in baseline function and increasing loss of independence.
Despite growing biomedical evidence, ME/ICC remains widely under-recognised in clinical practice. Many clinicians receive limited training in the condition, and its complex, multi-system nature combined with the lack of consistent routine biomarkers can contribute to misinterpretation of symptoms and underestimation of severity. As a result, patients are frequently dismissed or not fully believed, not necessarily due to intent, but due to persistent gaps in clinical understanding and outdated assumptions about the illness.
Closing the gap in ME/ICC care requires action at several levels; clinical education, diagnostics, healthcare systems, and patient protection. The key is shifting from misunderstanding and variability in practice toward consistency, validation, and biomedical literacy.
At the clinical level, a major step is improving medical education. ME/ICC needs to be properly integrated into undergraduate medical training, postgraduate programs, and continuing professional development. This includes teaching the ICC/updated biomedical models, post-exertional Neuroimmune exhaustion, autonomic and immune involvement, and the harms of inappropriate “graded exercise” approaches. Clinicians don’t just need awareness, they need practical competence in recognition and safe management.
Diagnosis is another critical gap. Earlier and more consistent use of validated diagnostic criteria, combined with structured clinical assessment tools, would reduce misdiagnosis and delay. Clinicians also need guidance on excluding common mimics while recognising that standard investigations can appear normal despite significant disability.
On the system side, care pathways should be formalised so patients are not left navigating fragmented services. Multidisciplinary models that include neurology, immunology, cardiology (for orthostatic intolerance), and rehabilitation medicine, grounded in energy-limiting principles, can reduce harm and improve continuity of care. Access to disability supports should also be based on functional impairment rather than fluctuating day-to-day presentation.
Equally important is shifting the clinical culture: validating patient-reported symptoms as clinically meaningful data, not subjective noise. ME/ICC is one of the conditions where patient history is central to diagnosis, and failing to treat it as such perpetuates under-recognition.
Finally, research investment needs to focus on proper stratification, objective biomarkers, metabolic dysfunction, neuroimmune dysregulation, and post-exertional pathophysiology. Without measurable biological targets, clinical uncertainty will continue to feed inconsistency in care.
In short, closing the gap means better education, clearer diagnostic practice, safer care pathways, and a stronger commitment to biomedical research paired with a cultural shift toward taking patient experience seriously as evidence, not opinion.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12346739/….
https://pmc.ncbi.nlm.nih.gov/articles/PMC3973969/….
https://www.sciencedirect.com/…/abs/pii/S0002934325000932
https://www.healthlinkbc.ca/…/myalgic…
https://pmc.ncbi.nlm.nih.gov/articles/PMC3973969/….
#NightingaleContinuum
#GAMEICC